{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:12:35Z","timestamp":1789409555041,"version":"build-2803163510"},"reference-count":102,"publisher":"Impact Journals, LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"DOI":"10.18632\/aging.206298","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T15:49:51Z","timestamp":1754754591000},"source":"Crossref","is-referenced-by-count":1,"title":["The myokine FGF21 associates with enhanced survival in ALS and mitigates stress-induced cytotoxicity"],"prefix":"10.18632","author":[{"given":"Abhishek","family":"Guha","sequence":"first","affiliation":[{"name":"Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA"},{"name":"Birmingham Veterans Affairs Medical Center, Birmingham, AL 35294, USA"},{"name":"Killion Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Si","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA"},{"name":"Birmingham Veterans Affairs Medical Center, Birmingham, AL 35294, USA"},{"name":"Killion Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reed","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA"},{"name":"Birmingham Veterans Affairs Medical Center, Birmingham, AL 35294, USA"},{"name":"Killion Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh K.","family":"Singh","sequence":"additional","affiliation":[{"name":"Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"},{"name":"Center for Neural Science and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benisa","family":"Zogu","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angad","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA"},{"name":"Killion Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Kazamel","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA"},{"name":"Birmingham Veterans Affairs Medical Center, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritchie","family":"Ho","sequence":"additional","affiliation":[{"name":"Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"},{"name":"Center for Neural Science and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"},{"name":"Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"},{"name":"Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Thalacker-Mercer","sequence":"additional","affiliation":[{"name":"Birmingham Veterans Affairs Medical Center, Birmingham, AL 35294, USA"},{"name":"Department of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaida A.","family":"Andrabi","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA"},{"name":"Killion Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao D. Tavares","family":"Da Silva Pereira","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA"},{"name":"Killion Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL 35294, USA"},{"name":"Department of Neuroscience, Yale University School of Medicine, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana S.","family":"Salgado","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Yale University School of Medicine, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasi","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Yale University School of Medicine, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emina Horvat","family":"Velic","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Yale University School of Medicine, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"King","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA"},{"name":"Birmingham Veterans Affairs Medical Center, Birmingham, AL 35294, USA"},{"name":"Killion Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, AL 35294, USA"},{"name":"Department of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3109\/21678421.2013.770030","article-title":"Epidemiological features of amyotrophic lateral sclerosis in a large clinic-based African American population.","volume":"1","author":"King","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrneurol.2011.153","article-title":"Clinical diagnosis and management of amyotrophic lateral sclerosis.","volume":"7","author":"Kiernan","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"3","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1007\/s12035-021-02658-6","article-title":"Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis.","volume":"5","author":"Taneja","year":"2022","journal-title":"Mol Neurobiol"},{"key":"4","doi-asserted-by":"publisher","first-page":"747","DOI":"10.4103\/1673-5374.382226","article-title":"Skeletal muscle as a molecular and cellular biomarker of disease progression in amyotrophic lateral sclerosis: a narrative review.","volume":"1","author":"King","year":"2024","journal-title":"Neural Regen Res"},{"key":"5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fnins.2014.00252","article-title":"ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease.","volume":"8","author":"Verhaagen","year":"2014","journal-title":"Front Neurosci"},{"key":"6","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1007\/s13311-022-01262-3","article-title":"Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis.","volume":"1","author":"Trotti","year":"2022","journal-title":"Neurotherapeutics"},{"key":"7","doi-asserted-by":"publisher","first-page":"16679","DOI":"10.1038\/s41598-020-73845-z","article-title":"Wnt antagonist FRZB is a muscle biomarker of denervation atrophy in amyotrophic lateral sclerosis.","volume":"1","author":"King","year":"2020","journal-title":"Sci Rep"},{"key":"8","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/acn3.117","article-title":"Smads as muscle biomarkers in amyotrophic lateral sclerosis.","volume":"1","author":"Morgan","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"9","doi-asserted-by":"publisher","first-page":"105650","DOI":"10.1016\/j.jsbmb.2020.105650","article-title":"The vitamin D activator CYP27B1 is upregulated in muscle fibers in denervating disease and can track progression in amyotrophic lateral sclerosis.","volume":"20","author":"King","year":"2020","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10","doi-asserted-by":"publisher","first-page":"e0138425","DOI":"10.1371\/journal.pone.0138425","article-title":"Transforming Growth Factor Beta (TGF-\u03b2) Is a Muscle Biomarker of Disease Progression in ALS and Correlates with Smad Expression.","volume":"1","author":"King","year":"2015","journal-title":"PLoS One"},{"key":"11","doi-asserted-by":"publisher","first-page":"9832","DOI":"10.18632\/aging.204450","article-title":"Transcriptomic analysis of human ALS skeletal muscle reveals a disease-specific pattern of dysregulated circRNAs.","volume":"1","author":"Singh","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.nbd.2018.02.009","article-title":"Muscle microRNA signatures as biomarkers of disease progression in amyotrophic lateral sclerosis.","volume":"11","author":"King","year":"2018","journal-title":"Neurobiol Dis"},{"key":"13","doi-asserted-by":"publisher","first-page":"7515","DOI":"10.3390\/ijms23147515","article-title":"Smad8 Is Increased in Duchenne Muscular Dystrophy and Suppresses miR-1, miR-133a, and miR-133b.","volume":"2","author":"King","year":"2022","journal-title":"Int J Mol Sci"},{"key":"14","first-page":"703","article-title":"Neuromuscular synaptogenesis: coordinating partners with multiple functions.","volume":"1","author":"Robitaille","year":"2014","journal-title":"Nat Rev Neurosci"},{"key":"15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mus.24979","article-title":"ALS biomarkers for therapy development: State of the field and future directions.","volume":"5","author":"Bruijn","year":"2016","journal-title":"Muscle Nerve"},{"key":"16","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3389\/fphys.2019.00419","article-title":"FGF21 as Modulator of Metabolism in Health and Disease.","volume":"1","author":"Sandri","year":"2019","journal-title":"Front Physiol"},{"key":"17","doi-asserted-by":"publisher","first-page":"1264530","DOI":"10.3389\/fendo.2023.1264530","article-title":"The roles of FGF21 and GDF15 in mediating the mitochondrial integrated stress response.","volume":"1","author":"Pereira","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41419-023-05842-9","article-title":"FGF21-FGFR1 controls mitochondrial homeostasis in cardiomyocytes by modulating the degradation of OPA1.","volume":"1","author":"Han","year":"2023","journal-title":"Cell Death Dis"},{"key":"19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","article-title":"Understanding the Physiology of FGF21.","volume":"7","author":"Maratos-Flier","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"20","doi-asserted-by":"publisher","first-page":"625287","DOI":"10.3389\/fphys.2021.625287","article-title":"Skeletal Muscle and Bone - Emerging Targets of Fibroblast Growth Factor-21.","volume":"1","author":"Li","year":"2021","journal-title":"Front Physiol"},{"key":"21","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s11357-020-00287-w","article-title":"Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer\u2019s disease in comparison with healthy aging.","volume":"4","author":"Salvioli","year":"2021","journal-title":"Geroscience"},{"key":"22","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1038\/s41467-022-29499-8","article-title":"FGF21 is required for protein restriction to extend lifespan and improve metabolic health in male mice.","volume":"1","author":"M\u00fcnzberg","year":"2022","journal-title":"Nat Commun"},{"key":"23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.cmet.2024.03.012","article-title":"The intersection of frailty and metabolism.","volume":"3","author":"Howlett","year":"2024","journal-title":"Cell Metab"},{"key":"24","doi-asserted-by":"publisher","first-page":"12062","DOI":"10.1038\/s41598-021-91496-6","article-title":"FGF23, a novel muscle biomarker detected in the early stages of ALS.","volume":"1","author":"King","year":"2021","journal-title":"Sci Rep"},{"key":"25","doi-asserted-by":"publisher","first-page":"7929","DOI":"10.1523\/JNEUROSCI.1877-07.2007","article-title":"Mutant Cu\/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression.","volume":"2","author":"King","year":"2007","journal-title":"J Neurosci"},{"key":"26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41467-017-02729-0","article-title":"C9ORF72 repeat expansion causes vulnerability of motor neurons to Ca-permeable AMPA receptor-mediated excitotoxicity.","volume":"9","author":"Nishimura","year":"2018","journal-title":"Nat Commun"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1101\/2023.11.13.566896","article-title":"Aberrant splicing exonizesrepeat expansion in ALS\/FTD.","author":"Guo","year":"2023","journal-title":"bioRxiv [Preprint]"},{"key":"28","doi-asserted-by":"publisher","first-page":"33989","DOI":"10.1074\/jbc.M109.067918","article-title":"Amyotrophic lateral sclerosis-linked mutant SOD1 sequesters Hu antigen R (HuR) and TIA-1-related protein (TIAR): implications for impaired post-transcriptional regulation of vascular endothelial growth factor.","volume":"28","author":"King","year":"2009","journal-title":"J Biol Chem"},{"key":"29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13395-022-00297-6","article-title":"The Myotube Analyzer: how to assess myogenic features in muscle stem cells.","volume":"1","author":"Desloovere","year":"2022","journal-title":"Skelet Muscle"},{"key":"30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/jnnp.2009.183525","article-title":"Incidence of amyotrophic lateral sclerosis in Europe.","volume":"8","author":"Beghi","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"31","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1093\/brain\/awt164","article-title":"Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.","volume":"13","author":"Pradat","year":"2013","journal-title":"Brain"},{"key":"32","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/brb3.142","article-title":"Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part II, results and discussion.","volume":"3","author":"Milligan","year":"2013","journal-title":"Brain Behav"},{"key":"33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s40478-014-0165-z","article-title":"Mitochondrial abnormalities and low grade inflammation are present in the skeletal muscle of a minority of patients with amyotrophic lateral sclerosis; an observational myopathology study.","volume":"2","author":"Meininger","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"34","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1210\/clinem\/dgac729","article-title":"Circulating FGF21 Concentration, Fasting Plasma Glucose, and the Risk of Type 2 Diabetes: Results From the PREVEND Study.","volume":"10","author":"Bakker","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"35","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1136\/jnnp-2015-310998","article-title":"Rate of disease progression: a prognostic biomarker in ALS.","volume":"8","author":"Vucic","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev-nutr-071816-064800","article-title":"Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis.","volume":"3","author":"Potthoff","year":"2018","journal-title":"Annu Rev Nutr"},{"key":"37","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.tips.2018.02.007","article-title":"Cysteine Metabolism in Neuronal Redox Homeostasis.","volume":"3","author":"Snyder","year":"2018","journal-title":"Trends in Pharmacological Sciences"},{"key":"38","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/s41467-023-36630-w","article-title":"Dietary restriction of cysteine and methionine sensitizes gliomas to ferroptosis and induces alterations in energetic metabolism.","volume":"1","author":"Argenziano","year":"2023","journal-title":"Nat Commun"},{"key":"39","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0921-8734(92)90043-o","article-title":"Cell culture models for oxidative stress: superoxide and hydrogen peroxide versus normobaric hyperoxia.","volume":"27","author":"Joenje","year":"1992","journal-title":"Mutat Res"},{"key":"40","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.cmet.2008.09.002","article-title":"Skeletal muscle is a primary target of SOD1G93A-mediated toxicity.","volume":"8","author":"Protasi","year":"2008","journal-title":"Cell Metab"},{"key":"41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s41232-023-00270-w","article-title":"Immune-mediated myogenesis and acetylcholine receptor clustering promote a slow disease progression in ALS mouse models.","volume":"4","author":"Sorar\u00f9","year":"2023","journal-title":"Inflamm Regen"},{"key":"42","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1016\/j.ymthe.2022.04.018","article-title":"Boosting the peripheral immune response in the skeletal muscles improved motor function in ALS transgenic mice.","volume":"3","author":"Nardo","year":"2022","journal-title":"Mol Ther"},{"key":"43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/bpa.12350","article-title":"The Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis.","volume":"2","author":"Gonzalez De Aguilar","year":"2016","journal-title":"Brain Pathol"},{"key":"44","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1074\/jbc.M109.041319","article-title":"Hyperactive intracellular calcium signaling associated with localized mitochondrial defects in skeletal muscle of an animal model of amyotrophic lateral sclerosis.","volume":"28","author":"Deng","year":"2010","journal-title":"J Biol Chem"},{"key":"45","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S1474-4422(11)70155-7","article-title":"FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study.","volume":"1","author":"\u00d5unap","year":"2011","journal-title":"Lancet Neurol"},{"key":"46","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1212\/WNL.0000000000003374","article-title":"FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders.","volume":"8","author":"Heli\u00f6","year":"2016","journal-title":"Neurology"},{"key":"47","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1093\/hmg\/ddq310","article-title":"Mitochondrial myopathy induces a starvation-like response.","volume":"1","author":"Pietil\u00e4inen","year":"2010","journal-title":"Hum Mol Genet"},{"key":"48","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrd2792","article-title":"The FGF family: biology, pathophysiology and therapy.","volume":"8","author":"Mohammadi","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"49","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1523\/JNEUROSCI.20-11-04099.2000","article-title":"Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies.","volume":"2","author":"van Kuppevelt","year":"2000","journal-title":"J Neurosci"},{"key":"50","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.2337\/db11-0672","article-title":"Fibroblast growth factor 21 (FGF21) in human cerebrospinal fluid: relationship with plasma FGF21 and body adiposity.","volume":"6","author":"Randeva","year":"2011","journal-title":"Diabetes"},{"key":"51","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1016\/j.peptides.2007.10.007","article-title":"The fasting polypeptide FGF21 can enter brain from blood.","volume":"2","author":"Kastin","year":"2007","journal-title":"Peptides"},{"key":"52","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3389\/fncel.2014.00464","article-title":"Gene expression changes in spinal motoneurons of the SOD1(G93A) transgenic model for ALS after treatment with G-CSF.","volume":"8","author":"Schneider","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"53","doi-asserted-by":"publisher","first-page":"102700","DOI":"10.1016\/j.isci.2021.102700","article-title":"Translatomic analysis of regenerating and degenerating spinal motor neurons in injury and ALS.","volume":"2","author":"Pierchala","year":"2021","journal-title":"iScience"},{"key":"54","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.celrep.2018.07.023","article-title":"Neuronal Mitochondrial Dysfunction Activates the Integrated Stress Response to Induce Fibroblast Growth Factor 21.","volume":"2","author":"Mallucci","year":"2018","journal-title":"Cell Rep"},{"key":"55","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1212\/WNL.0000000000000578","article-title":"Serum FGF21 levels in adult m.3243A>G carriers: clinical implications.","volume":"8","author":"Smeitink","year":"2014","journal-title":"Neurology"},{"key":"56","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1053\/j.gastro.2010.04.054","article-title":"Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.","volume":"13","author":"Maratos-Flier","year":"2010","journal-title":"Gastroenterology"},{"key":"57","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neurobiolaging.2022.07.005","article-title":"Fast versus slow disease progression in amyotrophic lateral sclerosis-clinical and genetic factors at the edges of the survival spectrum.","volume":"11","author":"Ludolph","year":"2022","journal-title":"Neurobiol Aging"},{"key":"58","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1212\/CPJ.0000000000000521","article-title":"Body mass index and survival from amyotrophic lateral sclerosis: A meta-analysis.","volume":"8","author":"Brotis","year":"2018","journal-title":"Neurol Clin Pract"},{"key":"59","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1212\/WNL.0000000000000951","article-title":"The PRO-ACT database: design, initial analyses, and predictive features.","volume":"8","author":"Leitner","year":"2014","journal-title":"Neurology"},{"key":"60","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1212\/CPJ.0b013e3182a1b8ab","article-title":"Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997-2011.","volume":"3","author":"Glass","year":"2013","journal-title":"Neurol Clin Pract"},{"key":"61","doi-asserted-by":"publisher","first-page":"e0251087","DOI":"10.1371\/journal.pone.0251087","article-title":"Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual-energy x-ray absorptiometry in a prospective study.","volume":"1","author":"King","year":"2021","journal-title":"PLoS One"},{"key":"62","doi-asserted-by":"publisher","first-page":"13292","DOI":"10.1038\/s41598-022-16229-9","article-title":"Correlation of weight and body composition with disease progression rate in patients with amyotrophic lateral sclerosis.","volume":"1","author":"Cui","year":"2022","journal-title":"Sci Rep"},{"key":"63","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/17482960802566824","article-title":"Prognostic factors in ALS: A critical review.","volume":"1","author":"Traynor","year":"2009","journal-title":"Amyotroph Lateral Scler"},{"key":"64","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/jnnp-2018-319611","article-title":"Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort.","volume":"9","author":"Chi\u00f2","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"65","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/ene.13468","article-title":"Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis.","volume":"2","author":"Couratier","year":"2018","journal-title":"Eur J Neurol"},{"key":"66","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1136\/jnnp-2017-317887","article-title":"Hypermetabolism in ALS is associated with greater functional decline and shorter survival.","volume":"8","author":"Ngo","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"67","doi-asserted-by":"publisher","first-page":"9137","DOI":"10.1523\/JNEUROSCI.1388-20.2020","article-title":"Neutral Lipid Cacostasis Contributes to Disease Pathogenesis in Amyotrophic Lateral Sclerosis.","volume":"4","author":"Shihabuddin","year":"2020","journal-title":"J Neurosci"},{"key":"68","doi-asserted-by":"publisher","first-page":"10812","DOI":"10.1073\/pnas.1308421110","article-title":"Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis.","volume":"11","author":"Shihabuddin","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"69","doi-asserted-by":"publisher","first-page":"11159","DOI":"10.1073\/pnas.0402026101","article-title":"Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model.","volume":"10","author":"Loeffler","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"70","doi-asserted-by":"publisher","first-page":"fcaa154","DOI":"10.1093\/braincomms\/fcaa154","article-title":"Altered skeletal muscle glucose-fatty acid flux in amyotrophic lateral sclerosis.","volume":"2","author":"Leevy","year":"2020","journal-title":"Brain Commun"},{"key":"71","doi-asserted-by":"publisher","first-page":"526","DOI":"10.15252\/emmm.201404433","article-title":"A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis.","volume":"7","author":"Ren\u00e9","year":"2015","journal-title":"EMBO Mol Med"},{"key":"72","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3390\/biom13050863","article-title":"Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models.","volume":"1","author":"Park","year":"2023","journal-title":"Biomolecules"},{"key":"73","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cmet.2016.09.001","article-title":"Defining the Nutritional and Metabolic Context of FGF21 Using the Geometric Framework.","volume":"2","author":"Wali","year":"2016","journal-title":"Cell Metab"},{"key":"74","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/ana.26825","article-title":"Higher Glycemic Index and Glycemic Load Diet Is Associated with Slower Disease Progression in Amyotrophic Lateral Sclerosis.","volume":"9","author":"Nieves","year":"2024","journal-title":"Ann Neurol"},{"key":"75","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s12967-024-05239-y","article-title":"FGF21 attenuates neuroinflammation following subarachnoid hemorrhage through promoting mitophagy and inhibiting the cGAS-STING pathway.","volume":"2","author":"Zhang","year":"2024","journal-title":"J Transl Med"},{"key":"76","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuroscience.2022.11.003","article-title":"Focus on Alzheimer\u2019s Disease: The Role of Fibroblast Growth Factor 21 and Autophagy.","volume":"51","author":"Nao","year":"2023","journal-title":"Neuroscience"},{"key":"77","doi-asserted-by":"publisher","first-page":"110145","DOI":"10.1016\/j.biopha.2020.110145","article-title":"Fibroblast growth factor 21 and autophagy: A complex interplay in Parkinson disease.","volume":"12","author":"Taliyan","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"78","doi-asserted-by":"publisher","first-page":"8430","DOI":"10.7150\/thno.44370","article-title":"Modulation of the Astrocyte-Neuron Lactate Shuttle System contributes to Neuroprotective action of Fibroblast Growth Factor 21.","volume":"1","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"79","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/WCO.0b013e328364c063","article-title":"Clinical implications of recent breakthroughs in amyotrophic lateral sclerosis.","volume":"2","author":"Robberecht","year":"2013","journal-title":"Curr Opin Neurol"},{"key":"80","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nrneurol.2015.57","article-title":"Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era.","volume":"1","author":"Feldman","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"81","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00221-023-06709-3","article-title":"Fibroblast growth factor-21 alleviates proteasome injury via activation of autophagy flux in Parkinson\u2019s disease.","volume":"24","author":"Zhang","year":"2024","journal-title":"Exp Brain Res"},{"key":"82","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1046\/j.1460-9568.1998.00100.x","article-title":"Basic and acidic fibroblast growth factors protect spinal motor neuronesafter experimental spinal cord injury.","volume":"1","author":"Wrathall","year":"1998","journal-title":"Eur J Neurosci"},{"key":"83","doi-asserted-by":"publisher","first-page":"7037","DOI":"10.1523\/JNEUROSCI.19-16-07037.1999","article-title":"Basic fibroblast growth factor increases long-term survival of spinal motor neurons and improves respiratory function after experimental spinal cord injury.","volume":"1","author":"Wrathall","year":"1999","journal-title":"J Neurosci"},{"key":"84","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s13311-020-00933-3","article-title":"Behavioral, Hormonal, Inflammatory, and Metabolic Effects Associated with FGF21-Pathway Activation in an ALS Mouse Model.","volume":"1","author":"Blasco","year":"2021","journal-title":"Neurotherapeutics"},{"key":"85","doi-asserted-by":"publisher","first-page":"8928","DOI":"10.1038\/s41598-022-12807-z","article-title":"Oxidative stress monitoring in iPSC-derived motor neurons using genetically encoded biosensors of HO","volume":"1","author":"Medvedev","year":"2022","journal-title":"Sci Rep"},{"key":"86","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","article-title":"Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation.","volume":"2","author":"Shaw","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"87","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.freeradbiomed.2015.03.020","article-title":"Skeletal muscle increases FGF21 expression in mitochondrial disorders to compensate for energy metabolic insufficiency by activating the mTOR-YY1-PGC1\u03b1 pathway.","volume":"8","author":"Yan","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"88","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/jcp.25735","article-title":"Fibroblast Growth Factor 21 (FGF21) Promotes Formation of Aerobic Myofibers via the FGF21-SIRT1-AMPK-PGC1\u03b1 Pathway.","volume":"23","author":"Zhao","year":"2017","journal-title":"J Cell Physiol"},{"key":"89","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1042\/BJ20140403","article-title":"FGF21 expression and release in muscle cells: involvement of MyoD and regulation by mitochondria-driven signalling.","volume":"46","author":"Villarroya","year":"2014","journal-title":"Biochem J"},{"key":"90","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3109\/01913123.2014.937842","article-title":"Skeletal muscle satellite cells in amyotrophic lateral sclerosis.","volume":"3","author":"Cenacchi","year":"2014","journal-title":"Ultrastruct Pathol"},{"key":"91","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000338061","article-title":"Alteredproliferation of mouse SOD1-G93A skeletal muscle satellite cells.","volume":"1","author":"Osta","year":"2013","journal-title":"Neurodegener Dis"},{"key":"92","doi-asserted-by":"publisher","first-page":"537853","DOI":"10.1155\/2015\/537853","article-title":"Postmitotic Expression of SOD1(G93A) Gene Affects the Identity of Myogenic Cells and Inhibits Myoblasts Differentiation.","volume":"201","author":"Musar\u00f2","year":"2015","journal-title":"Mediators Inflamm"},{"key":"93","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1038\/s41467-021-23224-7","article-title":"Locomotor deficits in a mouse model of ALS are paralleled by loss of V1-interneuron connections onto fast motor neurons.","volume":"1","author":"Kiehn","year":"2021","journal-title":"Nat Commun"},{"key":"94","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1523\/JNEUROSCI.20-07-02534.2000","article-title":"Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases.","volume":"2","author":"Caroni","year":"2000","journal-title":"J Neurosci"},{"key":"95","doi-asserted-by":"publisher","first-page":"655575","DOI":"10.3389\/fcvm.2021.655575","article-title":"The Roles and Pharmacological Effects of FGF21 in Preventing Aging-Associated Metabolic Diseases.","volume":"8","author":"He","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"96","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.arr.2018.07.004","article-title":"Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases.","volume":"4","author":"Peterson","year":"2018","journal-title":"Ageing Res Rev"},{"key":"97","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1093\/brain\/awz360","article-title":"Decoding the relationship between ageing and amyotrophic lateral sclerosis: a cellular perspective.","volume":"14","author":"Patani","year":"2020","journal-title":"Brain"},{"key":"98","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1113\/JP281647","article-title":"KLB dysregulation mediates disrupted muscle development in intrauterine growth restriction.","volume":"60","author":"Donadeu","year":"2022","journal-title":"J Physiol"},{"key":"99","doi-asserted-by":"publisher","first-page":"bqae004","DOI":"10.1210\/endocr\/bqae004","article-title":"FGF21 Induces Skeletal Muscle Atrophy and Increases Amino Acids in Female Mice: A Potential Role for Glucocorticoids.","volume":"16","author":"Ryan","year":"2024","journal-title":"Endocrinology"},{"key":"100","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/jcsm.12409","article-title":"Fibroblast growth factor 21 controls mitophagy and muscle mass.","volume":"1","author":"Romanello","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"101","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.cmet.2017.04.021","article-title":"Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence.","volume":"2","author":"Franceschi","year":"2017","journal-title":"Cell Metab"},{"key":"102","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.1074\/jbc.M115.710582","article-title":"Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21.","volume":"29","author":"Sonoda","year":"2016","journal-title":"J Biol Chem"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.206298","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T15:49:52Z","timestamp":1754754592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.206298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":102,"alternative-id":["206298"],"URL":"https:\/\/doi.org\/10.18632\/aging.206298","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]}}}